In vivo assessment of anti-helminthic and anti-inflammatory effects of Fucoidan on Schistosoma mansoni immature stages

Suzan H Elgendy, Wafaa A Aboukamar, Marwa M Hamouda, Amira Ismail, Rehab T Eldesoky, Ayat A Elblihy · 2026

Read In vivo assessment of anti-helminthic and anti-inflammatory effects of Fucoidan on Schistosoma mansoni immature stages by Suzan H Elgendy, Wafaa A Aboukamar, Marwa M Hamouda, Amira Ismail, Rehab T Eldesoky, Ayat A Elblihy (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13275806.txt.

Description

Suzan Elgendy and co-authors report a 2026 journal article on fucoidan, a substance from brown seaweed, as a possible treatment for schistosomiasis. This neglected tropical disease is caused by the worm Schistosoma mansoni. It scars the liver through long-lasting inflammation and tissue thickening.

The team infected forty-eight male mice and treated groups at set days after infection, comparing fucoidan with the standard drug and with no treatment. Fucoidan given at one, three, or five weeks cut worm counts, shrank inflamed lumps in the liver, and lowered scarring. It also reduced three chemical signals of inflammation in liver tissue. Treatment at six weeks helped less, which suggests timing matters. The authors propose fucoidan as a candidate for early treatment.

Catalog record

CREATORSuzan H Elgendy, Wafaa A Aboukamar, Marwa M Hamouda, Amira Ismail, Rehab T Eldesoky, Ayat A Elblihy
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39484
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13275806

Browse the full library · About the Tower of Babel